[ad_2]
CRANBURY, N.J., July 8, 2021 /PRNewswire/ — Pharmaceutical Executive®, a leading multimedia platform for industry leaders to exchange experiences and insights about innovative business and marketing ideas, is pleased to officially announce the finalists for the first annual Pharmaceutical Executive® 2021 APEX Awards.
“We are excited to announce the finalists for the Pharmaceutical Executive® APEX Awards that will be voted on by health care professionals in each specialty,” said Mike Hennessy Jr., president and CEO of MJH Life Sciences™, parent company of Pharmaceutical Executive®. “Our first-ever medical advertising awards allow us to highlight some of the leaders across multiple sectors of the industry. I look forward to seeing which agencies will have the honor of being named the winner in each category and to celebrating them this fall.”
Selected by an exceptional jury, comprising the most respected and experienced health care professionals across the United States, the finalists exemplify the best creative excellence and breakthroughs in pharmaceutical and health care marketing and communications within the industry.
The 2021 finalists are as follows:
Aesthetics/Dermatology
Cardiovascular
Devices
Direct-to-Consumer – FDA-Regulated
Direct-to-Consumer – Unregulated
Direct-to-Patient – FDA-Regulated
Direct-to-Patient – Unregulated
Hematology
Immunology
Metabolic
Oncology – FDA-Regulated
Oncology – Unregulated
Ophthalmology
Rare Disease – FDA-Regulated
Rare Disease – Unregulated
Respiratory
Surgery – FDA-Regulated
Women’s Health – FDA-Regulated
Women’s Health – Unregulated
The 2021 Pharmaceutical Executive® APEX Award gold winners for each of the 19 specialized categories will be announced on September 9, 2021, in New York City.
For the full list of categories and finalists, click here.
About Pharmaceutical Executive®
Pharmaceutical Executive® is a multimedia platform that offers news, opinion, analysis, features and executive profiles. The magazine and its website serve as a forum for industry leaders to exchange views, experiences and insights about innovative business and marketing ideas, strategies and tactics. Pharmaceutical Executive® is a brand of MJH Life Sciences™, the largest privately held, independent, full-service medical media company in North America, dedicated to delivering trusted health care news across multiple channels.
Pharmaceutical Executive® Media Contact
Alyssa Scarpaci, 609-250-4356
ascarpaci@mjhlifesciences.com
SOURCE Pharmaceutical Executive®
Source link
[ad_2]
The content is by PR Newswire. Headlines of Today Media is not responsible for the content provided or any links related to this content. Headlines of Today Media is not responsible for the correctness, topicality or the quality of the content.
[ad_2]
[ad_1] Nørresundby, 26 April 2024Announcement no. 23/2024 The Board of Directors of RTX has, cf. company announcement no. 20/2023 dated…
[ad_1] Gyroscope Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033 The Business Research Company's Gyroscope Global…
[ad_1] ODISHA, India, and LOS ANGELES, Calif., April 25, 2024 (SEND2PRESS NEWSWIRE) — In the 1880s, to call attention to…
In support of Hong Kong's new mega tourism and commerce drive, Alipay+ now enables users of 14 leading overseas mobile…
[ad_2] TOKYO, April 26, 2024 /PRNewswire/ -- KLab Inc. announced that its hit 3D action game Bleach: Brave Souls has…
[ad_1] CALGARY, Alberta, April 24, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of TransAlta Corporation (TSX: TA) (NYSE: TAC)…